Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Cash & Current Investments (2011 - 2026)

Iqvia Holdings' (IQV) quarterly Cash & Current Investments came in at $2.1 billion in Q2 2026, down 4.94% year-over-year from $2.2 billion in Q2 2025, and down 1.09% quarter-over-quarter from $2.1 billion in Q1 2026.

Analysis

Iqvia Holdings (IQV) Cash & Current Investments (2011 - 2026) Analysis & Trends

Iqvia Holdings has disclosed Cash & Current Investments across 16 years of filings, most recently posting $2.1 billion for Q2 2026.

  • In Q2 2026, Cash & Current Investments fell 4.94% year-over-year to $2.1 billion; the TTM figure through Jun 2026 stood at $2.1 billion (down 4.94% YoY), while the FY2025 annual figure was $2.1 billion, up 16.17% from the prior year.
  • Cash & Current Investments came in at $2.1 billion for Q2 2026 at Iqvia Holdings, down from $2.1 billion in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $2.2 billion in Q2 2025 to a low of $1.3 billion in Q4 2022.
  • Average Cash & Current Investments over 5 years is $1.7 billion, with a median of $1.6 billion recorded in 2023.
  • Year-over-year, Cash & Current Investments plunged 37.84% in 2022 and soared 30.39% in 2025.
  • Over 5 years, Cash & Current Investments stood at $1.3 billion in 2022, then climbed by 14.29% to $1.5 billion in 2023, then gained by 23.2% to $1.8 billion in 2024, then climbed by 16.17% to $2.1 billion in 2025, then fell by 2.85% to $2.1 billion in 2026.
  • Per Business Quant data, the three most recent Cash & Current Investments figures were $2.1 billion in Q2 2026, $2.1 billion in Q1 2026, and $2.1 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 2.08 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 502.69 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 928.39 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 192.03 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 168.60 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - 425.88 Mn
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 84.54 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 4.40 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 5.47 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.08 Bn
Mar 31, 2026 2.10 Bn
Dec 31, 2025 2.14 Bn
Sep 30, 2025 1.97 Bn
Jun 30, 2025 2.19 Bn
Mar 31, 2025 1.88 Bn
Dec 31, 2024 1.84 Bn
Sep 30, 2024 1.71 Bn
Jun 30, 2024 1.68 Bn
Mar 31, 2024 1.58 Bn
Dec 31, 2023 1.50 Bn
Sep 30, 2023 1.33 Bn
Jun 30, 2023 1.49 Bn
Mar 31, 2023 1.60 Bn
Dec 31, 2022 1.31 Bn
Sep 30, 2022 1.36 Bn
Jun 30, 2022 1.52 Bn
Mar 31, 2022 1.49 Bn
Dec 31, 2021 1.48 Bn
Sep 30, 2021 1.57 Bn